Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DR26FQQ3H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,467 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Skyrizi 360 mg/2.4 ml on-body applicator units on November 18, 2025. This non-set-aside, competitively awarded contract is scheduled for completion by December 10, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Skyrizi is a biologic immunosuppressant medication used to treat inflammatory skin conditions, representing the company's ongoing role as a critical pharmaceutical supplier to federal military and veteran healthcare systems.
This delivery order is a child contract issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialty medical supplies across multiple therapeutic domains to support military healthcare programs globally. The company's significant presence in federal pharmaceutical procurement, demonstrated through numerous competitively awarded contracts with the Defense Logistics Agency, reflects its established capability to meet the medical supply demands of the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FQQ3H?
SPE2DR26FQQ3H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FQQ3H worth?
The government has obligated $12,467 on SPE2DR26FQQ3H.
Is contract SPE2DR26FQQ3H an order under another contract?
Yes. SPE2DR26FQQ3H is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ3H competed?
The extent of competition for SPE2DR26FQQ3H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award